# Use of Stem Cells in Diabetes Mellitus Type 1

> **NCT02940418** · PHASE1 · UNKNOWN · sponsor: **Sophia Al-Adwan** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus Type 1

## Interventions

- **BIOLOGICAL:** Adipose mesenchymal cells with bone marrow mononuclear cells

## Key facts

- **NCT ID:** NCT02940418
- **Lead sponsor:** Sophia Al-Adwan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-19
- **Primary completion:** 2019-11
- **Final completion:** 2020-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02940418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02940418, "Use of Stem Cells in Diabetes Mellitus Type 1". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02940418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*